Biotechnology Pharmaceutical Marketing Firm Expands into Clinical Trial Marketing, Promotion & Recruitment
Synergy has been known as a biotechnology marketing firm and a pharmaceutical marketing firm since the agency opened its doors in 2002. Typically we’re on the periphery, helping medical suppliers and service firms (like CROs, laboratories and biological material providers) market and sell to hospitals and “big pharma.” We also represent several biotech companies, pharmaceutical firms and medical device manufacturers. Our successes in the life science sector has created several opportunities for Synergy to assist with the promotion and marketing of clinical trials.
One of these successes is ImmuneWorks, which is poised to commercialize the next block buster drug for idiopathic pulmonary fibrosis (IPF). Synergy refreshed the biotech firm’s brand image to more accurately reflect its scientific accomplishments, developed a new website to tell the company’s compelling R&D story, and is currently providing search engine optimization (SEO) and PR services to attract clinical trial participants from a dozen geographic markets around the country.
ImmuneWorks has been conducting research and development of treatments for serious autoimmune lung diseases for the last four years. The Phase I clinical trial will move the biotech company one step closer to commercialization of its lead treatment compound. Recruiting qualified participants is critical to the success of this clinical trial. The new SEO website Synergy developed is designed to reach and resonate with patients who suffer from IPF as well as their physicians, friends and family members (strong referral sources).
IPF is a devastating lung disease that is progressive and generally fatal. An estimated 128,000 persons in the United States suffer from IPF, with 48,000 new persons diagnosed with this devastating disease annually and 40,000 patients dying from the disease each year (source: Coalition for Pulmonary Fibrosis). The number of deaths annually is the same as breast cancer and greater than other cancers such as multiple myeloma.
The new website as well as SEO and PR efforts are designed to complement the grassroots clinical trial recruitment initiatives the principal investigators will conduct in nearly 12 leading academic research universities. Participating clinical trial centers include Indiana University; Medical University of South Carolina, Charleston; Ohio State University; University of Alabama-Birmingham; University of Chicago; University of Louisville; University of Michigan, Ann Arbor; and University of Vermont.
ImmuneWorks’ president and CEO, Wade Lange had this to say about Synergy: “We needed a new image and website that accurately represent the significant progress we have achieved in research and product development over the last several years. ImmuneWorks partnered with Synergy for website strategy, design and development due the marketing agency’s reputation for expertise in biotechnology marketing and healthcare marketing. Synergy understands the industry and the importance of clinical trials in the overall drug development and commercialization process.”
Since launching the new website and SEO and PR programs, ImmuneWorks has received a flood of requests from potential clinical trial participants. The faster the biotech firm can recruit qualified participants, the sooner it can begin actual drug testing and move closer to commercialization.
If your company needs assistance with clinical trial marketing, promotion or recruitment, please contact Synergy Marketing Group, an experienced biotechnology marketing firm and pharmaceutical marketing firm. We have proven strategies and methodologies that will condense your clinical trial recruitment timeline and ultimately save your organization money that is better invested in R&D and roll-out efforts. We also work with CROs in the clinical trial recruitment and promotion phase. Contact us today to schedule a complimentary consultation: 888-284-0555 ext. 222.